• THIS SITE IS INTENDED FOR AUSTRALIAN HEALTHCARE PROFESSIONALS

  • SOTYKTU Product Information

home
Indication

Treating
Patients

For GPs

For Specialists

Scientific
Evidence

Efficacy
Safety
QOL

What to
Expect

Expert
Opinions

Resources
My Profile Log Out

Code Login
Doccheck
Code Login
Inami Login
Doccheck
Doccheck
Inami Login
Code Login
Inami Login
Failed
 

Welcome to the SOTYKTU® (deucravacitinib) patient support site

This site is intended for people who have been prescribed SOTYKTU by an Australian healthcare professional (your doctor), and contains information about your condition and treatment with SOTYKTU, as well as downloadable support materials.

To access, please enter the last 4 digits of the barcode on your box of SOTYKTU:



Error
Error
Success
Success

Abbreviations

PBS Information: PBS listed. Authority Required [Streamlined]. Please refer to www.pbs.gov.au website .

Inverted triangle

This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems.

Before prescribing, please refer to the approved Product Information available here or by contacting Bristol Myers Squibb Australia Medical Information, telephone: 1800 067 567, email: MedInfo.Australia@bms.com

Bristol Myers Squibb logo
Legal Notice | Privacy Policy | Contact Us | Modern Slavery Statement

©2025 Bristol-Myers Squibb. SOTYKTU® is a registered trademark of Bristol-Myers Squibb Company. BMS Medical Information: 1800 067 567.
Bristol-Myers Squibb Australia Pty Ltd, Level 2, 4 Nexus Court, Mulgrave, VIC 3170. May 2025 BMS3490. 1787-AU-2300171.